Aaron Cook
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Aaron Cook sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Aaron Cook: 3 sponsored US clinical trials, 1 recruiting.
Aaron Cook sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Subarachnoid Hemorrhage, Aneurysmal, with 1 trials.
Upper-quartile sponsor footprint
Aaron Cook sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
NCT06119061
Fluorescent Probe for Assessment of Renal Elimination
NCT07643467
Continuous vs. Intermittent Infusion Vancomycin
NCT05823116
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 3 |
Therapeutic Areas
Where Aaron Cook enrollment is open (later-stage tilt)
1 recruiting of 3 indexed (33% open); 1 completed (33%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Subarachnoid Hemorrhage, Aneurysmal (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Aaron Cook: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Aaron Cook sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
- Adagio Medical · 33% recruiting · 3 trials
Related
What to do with this Aaron Cook page
3 registered trials is a research-attention snapshot, not an endorsement of Aaron Cook or any single study.
- 1 of Aaron Cook's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Subarachnoid Hemorrhage, Aneurysmal is the condition Aaron Cook studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Subarachnoid Hemorrhage, Aneurysmal trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Aaron Cook pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.